Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 11, Issue 14 pp 5058—5069
miR-548d-3p inhibits osteosarcoma by downregulating KRAS
Figure 2. MiR-548d-3p inhibits KRAS in osteosarcoma cells. (A) Correlation analysis between miR-548d-3p and KRAS expression. The correlation formula was y=-0.4602x+0.9542. (B) A luciferase reporter gene assay confirmed that miR-548d-3p could bind to KRAS. The results represent the mean±SD of three independent experiments. **P < 0.05 vs. control. (C–J) The protein and mRNA levels of KRAS were measured in MG63 and U2-OS cells by Western blotting and real-time PCR, respectively. The results represent the mean±SD of three independent experiments. **P < 0.05 vs. control.